Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Díaz Sánchez A, Núñez Martínez O, Prieto Martín M, Beceiro Pedreño I, Calleja Kempin J, Santos Castro L, Muro de la Fuente A, Clemente Ricote G, Matilla Peña A. [Prognostic factors in patients with non-active treatment of hepatocellular carcinoma]. Gastroenterol Hepatol 2007;30:441-8. [PMID: 17949609 DOI: 10.1157/13110488] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]

For:	Díaz Sánchez A, Núñez Martínez O, Prieto Martín M, Beceiro Pedreño I, Calleja Kempin J, Santos Castro L, Muro de la Fuente A, Clemente Ricote G, Matilla Peña A. [Prognostic factors in patients with non-active treatment of hepatocellular carcinoma]. Gastroenterol Hepatol 2007;30:441-8. [PMID: 17949609 DOI: 10.1157/13110488] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]

Number	Cited by Other Article(s)
1	Spinzi G, Paggi S. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:2497-8; author reply 2498-9. [PMID: 19052134 DOI: 10.1056/nejmc081780] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Abstract Collapse Key Words Collapse MESH Headings Benzenesulfonates/adverse effects Benzenesulfonates/therapeutic use Carcinoma, Hepatocellular/drug therapy Humans Hypertension/chemically induced Incidence Liver Neoplasms/drug therapy Niacinamide/analogs & derivatives Phenylurea Compounds Protein Kinase Inhibitors/adverse effects Protein Kinase Inhibitors/therapeutic use Pyridines/adverse effects Pyridines/therapeutic use Quality of Life Sorafenib Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Spinzi G, Paggi S. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:2497-8; author reply 2498-9. [PMID: 19052134 DOI: 10.1056/nejmc081780] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]